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ABSTRACT: One hundred Hampshire × Duroc cross-
bred pigs and 100 Nebraska Index line pigs were infected 
with porcine reproductive and respiratory syndrome vi-
rus (PRRSV) and evaluated for resistance and suscep-
tibility. Controls (100/line) were uninfected littermates 
to infected pigs. Viremia (V), BW change (WTΔ), and 
rectal temperature at 0, 4, 7, and 14 d postinfection 
were recorded. Lung, bronchial lymph node (BLN), and 
blood tissue were collected at necropsy (14 d postinfec-
tion). Infected pigs were classified as low or high re-
sponders to PRRSV based on the first principal compo-
nent from principal component analyses of all variables. 
Low responders to PRRSV (low PRRSV burden) and 
their uninfected littermates were assigned to the low 
(L) class. High responders to PRRSV (high PRRSV 
burden) and their uninfected littermates were assigned 
to the high (H) class. Infected pigs in the L class had 
large WTΔ, low V, and few lung lesions; H-class pigs 
had small WTΔ, high V, and many lung lesions. Ribo-
nucleic acid was extracted from lung and BLN tissue of 
the 7 highest and 7 lowest responders per line and from 
each of their control littermates. A control reference 
design was used, and cDNA from each reference sample 
tissue was prepared from pooled RNA extracted from 
2 control pigs from each line whose infected littermates 
had a principal component value of 0. Design variables 
in data analyses were line (Index vs. Hampshire × Du-
roc), class (H vs. L), treatment (infected vs. uninfected 
controls), and slide/pig as error. Oligo differential ex-
pression was based on P < 0.01 occurring in both lung 
and BLN. Line and treatment effects were significant 
for 38 and 541 oligos, respectively, in both lung and 
BLN. Line × class interaction existed for expression 
of thymosin β-4, DEAD box RNA helicase 3, acetyl-
cholinesterase, and Homo sapiens X (inactive)-specific 
transcript in both tissues. Treatment × class existed 
for expression of CCAAT/enhancer-binding δ protein, 
nuclear factor of κ light polypeptide gene enhancer in B 
cells inhibitor α, thioredoxin-interacting protein, major 
facilitator superfamily domain containing 1, and un-
known sequences SS00012040 and SS00012343. Line × 
treatment and line × treatment × class interactions 
were not significant. Possible important genetic asso-
ciations for fine-mapping candidate genes related to 
response to PRRSV and determining causative alleles 
were revealed.
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INTRODUCTION
Porcine reproductive and respiratory syndrome virus 
(PRRSV) is one of the most economically important 
diseases of swine and causes reproductive failure, inter-
stitial pneumonia, and weak piglets (Neumann et al., 
2005). The virus targets alveolar macrophages (Mur-
taugh et al., 2002; Osorio, 2002) and induces apoptosis. 
Infected pigs are ineffective in eliminating the virus, 
and it may persist for several weeks to months postin-
fection (Labarque et al., 2003; Rowland et al., 2003; 
Chang et al., 2005).
Porcine reproductive and respiratory syndrome vi-
rus, a single-stranded 15-kb RNA-enveloped virus of 
positive polarity, contains 7 open reading frames (Al-
lende et al., 1999). Its genome is highly variable, spe-
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cifically between the North American and European 
isolates, due in part to many years of antigenic drift 
(Plagemann, 2003). Because of this variability, no ef-
fective vaccine against all PRRSV isolates currently ex-
ists. Therefore, alternative methods such as the use of 
genetic markers to select animals resistant or tolerant 
to PRRSV would be useful.
Studies with microarrays, which allow simultaneous 
assessment of mRNA transcription patterns of thou-
sands of genes, have been used to identify genes and 
pathways involved in immune response to pathogens 
(Hernandez et al., 2003; de Koning et al., 2005). Mi-
croarray technology can determine changes of gene 
expression, host and virus interactions, and potential 
pathways for viral pathogenesis.
Breeds and lines of pigs respond differently to infec-
tion with PRRSV (Halbur et al., 1998; Lowe et al., 
2005; Petry et al., 2005; Vincent et al., 2006), indicat-
ing that genetic variation in pigs in response to PRRSV 
exists. It is not practical to infect pigs in commercial 
populations with PRRSV, measure their response, and 
then select for resistance using quantitative methods. 
Therefore, selection for resistance using genetic mark-
ers or traits that can be measured in uninfected pigs 
seems more practical. The purpose of this experiment 
was to identify genes expressed differently in lung and 
bronchial lymph node (BLN) in pigs infected with 
PRRSV and then classified as susceptible or tolerant/
resistant and in their uninfected littermates.
MATERIALS AND METHODS
This research was approved by the University of Ne-
braska Institutional Animal Care and Use Committee.
PRRSV Infection Experiment
A gene expression study was conducted with 56 pigs 
from a PRRSV infection experiment involving a total 
of 400 pigs. Design of the experiment and details of the 
infection and tissue collection procedures are in Petry 
et al. (2005). An overview is presented here.
Two hundred pigs from the Nebraska Index line (I), 
selected 20 generations for increased litter size, and 
200 pigs from a commercial Hampshire × Duroc (HD) 
cross-selected for lean growth, were used. Johnson et 
al. (1999) described the selection history of line I. Re-
sponses in reproductive traits through generation 19 
are reported in Petry and Johnson (2004). Two pigs 
of the same sex from each available litter, represent-
ing 83 sires and 163 dams, were selected at random 
for the experiment. A total of 200 pigs were infected 
with PRRSV, and 200 uninfected littermates served as 
controls. The experiment was conducted in 2 replicates 
within each of 2 seasons with 50 pigs per breed in each 
year-season-replicate.
Pigs were housed in 2 isolation rooms at the Univer-
sity of Nebraska Animal Research Facility of the Veteri-
nary and Biomedical Sciences Department. Each room 
contained 2 pens of 12 to 13 pigs per pen, with line I 
pigs in one pen and line HD pigs in the other pen. One 
room was randomly assigned for treatment, and pigs 
in it were inoculated intranasally with 105 cell culture 
infectious dose 50% (of PRRSV strain 97-7985; Osorio 
et al., 2002). Application rate was 1 cc per nostril. Lit-
termates, serving as controls to the infected pigs, were 
placed in the second room.
Blood (3 to 5 mL per pig) was collected from the 
jugular vein of pigs using 6.0-mL SS tube with silica 
clot activator, polymer gel, silicone-coated interior BD 
Vacutainer Systems preanalytical solutions tube No. 
367974 (BD Biosciences, San Jose, CA). Blood samples 
were placed on ice for approximately 2 h and then se-
rum was isolated by centrifugation at 1,464 × g for 10 
min at 10°C. Phenotypic data included viremia from 
serum samples collected at 4, 7, and 14 d postinfection 
(dpi), changes in BW, and rectal temperature from 0 
to 4, 4 to 7, and 7 to 14 dpi; lung and BLN viremia 
from tissue collected at necropsy at d 14; and severity 
of lung lesions. Blood serum at d 0 before infection was 
collected and stored. Shin and Molitor (2002) reported 
that more than 80% of infected pigs showed the peak 
concentration of viral RNA concentrations in serum at 
5 dpi and began to clear the virus thereafter. Work by 
Osorio (2002) also indicated that early clinical signs of 
PRRSV are evident in the early postinoculation period 
and that viremic titers are at maximum by d 14. Based 
on these results, in addition to sampling at d 0, blood 
samples were collected at 4, 7, and 14 dpi to monitor 
changes during and shortly after the acute phase of 
viral infection.
Line I and line HD pigs responded differently to in-
fection with PRRSV (Petry et al., 2005), indicating ge-
netic variation in response to infection. Uninfected HD 
pigs gained more BW and had greater rectal tempera-
ture from 0 to 14 dpi than uninfected I pigs, whereas 
infected I pigs gained more BW and had lower tem-
perature than infected HD pigs. Viremia (cell culture 
infectious dose 50%/mL) was also greater in HD than I 
pigs at 4, 7, and 14 dpi. Genetic line differences in lung 
and lymph viremia concentrations were not significant, 
but tended to be greater in HD than I pigs. Based on 
these results, the current microarray experiment was 
designed to determine whether expression of genes dif-
fered between pigs in the tails of the PRRSV response 
distribution.
Phenotypic data for infected pigs were subjected to 
principal component (PC) multivariate procedures to 
identify 28 pigs, 7 pigs within each line in the outermost 
tails of the distributions of viral response variables. The 
first PC eigenvector, which accounted for 27% of the 
variation, was used to rank pigs. The 28 control litter-
mates to each of these pigs were also selected, resulting 
in 56 pigs used in the gene expression experiment. In-
fected pigs in the right tail of the PC distribution were 
considered to be susceptible to PRRSV. Those pigs and 
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their control littermates formed the high PRRSV bur-
den (H) class. Pigs in the left tail were considered to be 
tolerant or resistant. They and their control littermates 
formed the low PRRSV burden (L) class. Phenotypes 
of H- and L-class pigs, and expression differences of 
11 specific immune function genes in these pigs, are 
reported by Petry et al. (2007).
A 2 × 2 × 2 factorial treatment design was utilized 
for the gene expression experiment. Design effects in-
cluded class (H and L), line (I and HD), and treatment 
(infected and uninfected), with 7 pigs in each of the 8 
categories. Petry et al. (2007) provided evidence that 
characterization into H and L classes was not likely 
confounded with other types of infection.
Tissue Storage and RNA Preparation
Lung and BLN tissue were collected at necropsy, 
placed in Optimal Cutting Temperature Compound 
(Sakura Finetec USA Inc., Torrance, CA), snap frozen 
in liquid nitrogen, and stored at −80°C. The RNA from 
the tissues of the 56 pigs was extracted with Trizol as 
described by Royaee et al. (2004) and Dawson et al. 
(2005). Integrity, quantity, and quality of RNA were 
assessed using the Agilent Bioanalyzer 2100 and RNA 
6000 Labchip Kit (Agilent Technologies, Palo Alto, 
CA) described by Mueller et al. (2004). In a review, 
Schroeder et al. (2006) discuss application of this in-
strument for assigning integrity values to RNA mea-
surements. The RNA was treated with DNase before 
cDNA synthesis using the Superscript Reverse Tran-
scriptase (Invitrogen, Carlsbad, CA) and oligo-dT. The 
reverse transcription PCR primers and TaqMan probes 
were designed with Primer Express and manufactured 
by BioSource (Invitrogen; Dawson et al., 2005). Nor-
malization of the samples was performed by using a 
standard amount of RNA (10 µg) for every sample 
for the cDNA production and confirmed by the cycle 
threshold value for the housekeeping gene RPL32. The 
reverse transcription PCR analyses were conducted in 
duplicate on 100 ng of cDNA/25 µL reaction per well 
utilizing the Stratagene Brilliant Kit (La Jolla, CA) 
and an Applied Biosystems PRISM 7700 Sequence De-
tector System (Foster City, CA). Conditions used for 
amplification were as follows: 50°C for 2 min, 95°C for 
10 min, 40 cycles of 95°C for 15 s, 60°C for 1 min, and 
then remaining at 4°C.
Porcine Microarray and Oligonucleotides
The 13,297 oligonucleotides (porcine AROS 1.0/1.0 
Extension; http://www.quiagen.com; last accessed Oct. 
2, 2008) used in this experiment were an accumula-
tion of porcine cDNA and expressed sequence tags and 
were designed from TIGR Tentative Consensus (SsGI 
Release 5.0). Zhao et al. (2005) showed that of these 
oligonucleotides, 8,541 uniquely matched human or 
mouse reference sequences or pig annotated gene Na-
tional Center for Biotechnology Information accession 
numbers, indicating a high specificity of the array. The 
oligonucleotides were synthesized at the University of 
Minnesota microarray facility. 
Microarray Design
A control reference design was used. The reference 
sample was developed from uninfected control full sib-
ling littermates of infected pigs that had a PC value 
of 0 and that were not included in the sample of 28 
infected pigs used in the microarray experiment. Two 
pigs from line I and 2 pigs from line HD made up the 
reference sample. One microarray assay per experimen-
tal pig, with the reference sample included in each one, 
was conducted. Thus, every sample of interest was com-
pared indirectly through the connection with the refer-
ence sample.
Two micrograms of total RNA was reverse-transcribed 
using oligo-dT primer and reagents from the Ambion 
Amino Allyl MessageAmp aRNA Amplification Kit 
(Ambion, Austin, TX; Van Gelder et al., 1990). After 
cRNA generation, 5 µg of cRNA was coupled to either 
CY5 or CY3 depending upon the sample. The samples 
were hybridized overnight using Ambion slide hyb buf-
fer at 42°C for 16 h. Slides were washed per the sug-
gestions of the manufacturers and were scanned with 
an Axon 4000B scanner. In total, 112 oligo microarray 
slides were used: 56 for lung and 56 for BLN.
Microarray Analysis
Medians were normalized by adjusting out a common 
median point. Global median normalization, which 
shifts the center of the distribution of the log ratio of 
635/532 to zero, but does not affect the spread within 
the slide, was performed to remove systematic varia-
tion across slides. Data points falling in the range of 
−150 to 150 in intensity value and those with ratios less 
than −15 and greater than 15 were removed. Also, data 
generated from microarray spots with problems (i.e., 
scratches, smears, etc.) were not used.
Variation is expected within slides; however, system-
atic bias within slides is not expected to be repeated 
across slides. Therefore, Lowess normalization, which is 
intended to remove systematic intensity dye bias and 
outliers, was not performed. Each slide represented 
1 pig, and variation among the 7 experimental units 
within each line-treatment-class category includes slide 
and pig variation.
Background adjustments for the Cy3 and Cy5 in-
tensity medians were made. Statistical analyses, which 
used a linear mixed model after normalization of the 
data, were performed on the ratio of medians. The ratio 
of medians is defined as: (median foreground intensity 
of Cy5 − median background intensity of Cy5) divid-
ed by (median foreground intensity of Cy3 − median 
background intensity of Cy3). The statistical model in-
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cluded line, treatment, class, and all possible interac-
tions as fixed effects. Litter within class by line was 
included as a random effect. Age of pig was fitted as a 
covariate.
Twenty-four oligos were repeated either 12 or 17 
times within each slide. Data for these oligos were fit-
ted to the same mixed model with spot within slide 
included to account for repeated measures.
Correlations in gene expression patterns for 11 im-
mune function genes between lung and BLN were weak 
(Petry et al., 2007), indicating that patterns for one 
tissue cannot be extrapolated to other tissues. There-
fore, expression data for lung and BLN tissues were 
analyzed separately using the SAS software (SAS Inst. 
Inc., Cary, NC). However, considering all genes on the 
array used in this experiment, it is expected that some 
expression patterns may be highly correlated between 
lung and BLN.
To minimize the number of false positives, a thresh-
old of P < 0.01 was used for each oligo in BLN and in 
lung. To control false positive rate, the P-values were 
subcategorized by tissue for each effect in the model 
(line × treatment × class, treatment × class, line × 
class, line × treatment, line, treatment, and class). If, 
for any oligo, true expression differences for effects in 
the model (treatments, classes, lines, or interaction ef-
fects) do not exist, then P-values for these effects across 
tissues are expected to be independent. For these oli-
gos, false positive rates in lung are uncorrelated with 
those in BLN. Therefore, the effects in the model for 
an oligo were considered to be significant if the P-value 
was less than 0.01 in both BLN and lung. With that 
assumption, the probability of a false positive occurring 
in both tissues is less than or equal to 0.0001.
RESULTS
Means for the 7 H and 7 L pigs within each line and 
means and SD for all infected pigs were reported by 
Petry et al. (2007) and are in Table 1 to illustrate phe-
notypic differences among pigs for which gene expres-
sions were evaluated. All pigs challenged with PRRSV 
became infected as indicated by the 4 dpi viremia val-
ues, but L-class pigs in both populations began to clear 
the virus more quickly and thus had less viremia at 7 
and 14 dpi, whereas H-class pigs had a continual in-
crease in viremia from d 4 to 14. Pigs in the L class also 
had increasing BW change after infection with PRRSV, 
whereas pigs in the H class had minimal or negative 
BW change.
Gene Expression
The experiment was designed to identify genes that 
are expressed differently between pigs infected with 
PRRSV and uninfected littermates, genes expressed 
differently between high and low responders, and to 
determine whether these expression patterns are consis-
tent across 2 distinctly different populations. To address 
these objectives, genes for which main effects signifi-
cantly affected expression patterns are presented first, 
followed by those genes for which interactions among 
main effects in expression patterns were significant.
Line, Treatment, and Class Effects. Line was 
significant (P < 0.01) for 76 oligos in lung, 358 in BLN, 
and 38 in both tissues. Treatment was significant for 
1,027 oligos in lung, 1,398 in BLN, and 541 in both tis-
sues. Class was significant for 75 oligos in lung, 50 in 
BLN, but none in both lung and BLN.
Table 1. Overall line means ( X ), SD, and means for the 7 high (H+) and low (L+) 
responders for Index (I) and Hampshire-Duroc (HD) cross pigs infected with porcine 
reproductive and respiratory syndrome virus 
Trait1
Line I Line HD
X SD H+ L+ X SD H+ L+
V4 4.17 0.60 4.39 4.11 4.54 0.82 5.11 3.10
V7 3.91 0.76 4.47 3.20 4.40 0.70 5.13 3.64
V14 3.00 1.21 4.49 0.50 3.59 0.99 5.29 2.51
WC0–4 0.32 0.39 0.08 0.58 0.29 0.34 −0.04 0.53
WC4–7 0.33 0.41 −0.01 0.92 0.06 0.33 −0.18 0.37
WC7–14 1.35 0.79 0.31 2.21 0.71 0.78 −0.57 1.80
TC0–4 0.92 1.56 1.09 0.33 1.76 1.46 0.79 1.94
TC4–7 0.58 1.25 1.00 0.66 0.82 1.70 1.36 −0.06
TC7–14 −0.16 1.17 0.36 −1.01 −0.36 1.63 −2.84 −0.26
LV 3.96 1.28 5.07 2.40 4.45 0.78 4.71 4.21
LNV 2.55 1.30 3.33 1.31 3.12 0.99 3.70 2.66
L 1.26 0.79 1.57 1.00 1.96 0.57 1.57 2.00
1V4, V7, and V14 = viremia titer, expressed as log10 cell culture infectious dose 50% (CCID50)/mL, in serum 
collected at 4, 7, and 14 d, respectively (SEM = 0.07); WC0–4, WC4–7, and WC7–14 = BW change (kg) from d 0 
to d 4, d 4 to d 7, and d 7 to d 14, respectively (SEM = 0.05); TC0–4, TC4–7, and TC7–14 = temperature change 
(°C) from d 0 to d 4, d 4 to d 7, and d 7 to d 14, respectively (SEM = 0.10); LV and LNV = viral titer (log10 
CCID50/mL) in lung (SEM = 0.11) and bronchial lymph (SEM = 0.07), respectively, collected at necropsy on 
d 14; L = severity score of lung lesions (SEM = 0.12).
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Although line, treatment, and class effects were not 
significant in both tissues for some oligos, oligos for 
which these effects were significant in at least 1 tissue 
may be of interest to others studying genetic resistance 
to PRRSV. Therefore, nucleotide number and results 
for these oligos are reported for line, treatment, and 
class effects in supplementary Tables 1, 2, and 3, re-
spectively (http://jas.fass.org/content/vol86/issue12).
The supplementary table of the online version of Zhao 
et al. (2005) contains additional information about 
genes listed in the supplementary tables of this manu-
script, including the oligonucleotide sequence and the 
gene that the sequence represents. Main effects of line, 
treatment, and class will not be discussed further.
Line × Class Interactions. Line × class inter-
action existed (Table 2) for 4 oligos in both lung and 
BLN: DEAD box RNA helicase 3 (DDX3), thymosin 
β-4 (Tβ4), acetylcholinesterase (ACHE), and Homo 
sapiens X (inactive)-specific transcript (XIST). Mean 
fold differences in expression of these genes are pre-
sented in Table 3.
Significant differences in expression of all 4 of these 
genes occurred between L-class and H-class pigs in line 
I, but not in line HD. Expression of DDX3 in line I was 
2.72 times greater in lung of L-class pigs (1.96 vs. 0.72) 
and 3.25 times greater in BLN (1.95 vs. 0.60) than in 
H-class pigs, compared with ratios of 0.99 (lung) and 
1.24 (BLN) of line HD, L-class to H-class pigs.
Expression of Tβ4 was 3.8 times greater (1.79 vs. 
0.47) in the lung and 3.1 times greater (1.83 vs. 0.59) in 
the BLN in line I L-class than H-class pigs. Greater ex-
pression in HD, L-class than H-class pigs also occurred, 
but the relative differences were much less (1.26-fold 
increase in lung and 1.74-fold increase in BLN).
Conversely, expression of ACHE and XIST was sig-
nificantly less in line I, L-class than in H-class pigs. The 
fold differences in expression of ACHE were 0.33 in lung 
(0.42 vs. 1.28) and 0.38 (0.44 vs. 1.16) in BLN. These 
Table 2. Genes and oligonucleotide identification number (ID) for which line × class and treatment × class were 







 Homo sapiens DEAD box RNA helicase 3 (DDX3) SS00006751 0.0014 0.00007
 Thymosin β-4 (Tβ4) SS00008272 0.0002 0.0029
 Acetylcholinesterase (ACHE) SS00011278 0.0043 0.0014
 Homo sapiens X (inactive)-specific transcript (XIST) SS00012135 0.0015 0.0065
Treatment × class
 Nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α (NF-κBIα) SS00000892 0.0013 0.0086
 Thioredoxin-interacting protein (TXNIP) SS00008321 0.0017 0.0026
 Major facilitator superfamily domain containing 1 (MFSD1) SS00009186 0.0078 0.0069
 CCAAT/enhancer-binding δ protein (CEBPδ) SS00010698 0.000007 0.0081
 Unknown SS00012040 0.0004 0.0016
 Unknown SS00012343 0.0073 0.0027
1Oligonucleotide sequence, TIGR Tentative Consensus accession, and reference sequence ID can be found in the supplementary table of the 
online version of Zhao et al., 2005 (http://jas.fass.org/content/vol86/issue12).
Table 3. Fold differences, relative to common control, in expression of genes in lung and bronchial lymph node 






High viremia Low viremia High viremia Low viremia
I HD SE I HD SE I HD SE I HD SE
DDX32 SS00006751 0.72 0.69 0.19 1.96 0.68 0.24 0.60 0.51 0.12 1.95 0.63 0.15
Tβ4
3 SS00008272 0.47 0.42 0.16 1.79 0.53 0.17 0.59 0.31 0.18 1.83 0.54 0.19
ACHE4 SS00011278 1.28 1.46 0.13 0.42 1.43 0.16 1.16 1.34 0.11 0.44 1.33 0.13
XIST5 SS00012135 1.18 1.32 0.12 0.32 1.24 0.07 1.11 1.33 0.13 0.43 1.34 0.14
1Oligonucleotide sequence, TIGR Tentative Consensus accession, and reference sequence identification numbers (ID) can be found in the supple-
mentary table of the online version of Zhao et al., 2005 (http://jas.fass.org/content/vol86/issue12).
2DDX3 = DEAD box RNA helicase 3.
3Tβ4 = thymosin β-4.
4ACHE = acetylcholinesterase.
5XIST = Homo sapiens X (inactive)-specific transcript.
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same ratios for expression of XIST were 0.27 (0.32 vs. 
1.18) in lung and 0.39 (0.43 vs. 1.11) in BLN. Again, 
differences in line HD in expression of these genes be-
tween L-class and H-class pigs were small.
Treatment × Class. Treatment × class interaction 
existed (Table 2) for expression of 6 oligos in both lung 
and BLN: nuclear factor of κ light polypeptide gene 
enhancer in B cells inhibitor α (NF-κBIα), thiore-
doxin-interacting protein (TXNIP), major facilitator 
superfamily domain containing 1 (MFSD1), CCAAT/
enhancer-binding δ protein (CEPBδ), and 2 unknown 
oligos, identification number (ID) = SS00012040 and 
ID = SS00012343. Mean fold differences in expression 
of these genes are presented in Table 4.
Increased expression of all 6 oligos occurred in both 
lung and BLN of pigs infected with PRRSV and that 
had a high PRRSV burden (H class) compared with 
their uninfected littermates (Table 4). Fold differences 
ranged from 1.27 (0.66 vs. 0.52) for expression of NF-
κBIα in BLN to 1.93 (1.47 vs. 0.76) for expression of 
unknown oligo (ID = SS00012040) in lung. However, in 
pigs with low PRRSV burden (L class), no consistent 
pattern existed in expression differences between infect-
ed and uninfected pigs. Fold differences in expression 
of these genes between L class infected and uninfected 
littermates ranged from 0.77 to 1.45.
DISCUSSION
Genetic variation for disease resistance is due to ef-
fects of genes that regulate innate and adaptive immune 
responses. Variation in gene expression among pigs and 
differences between lung and bronchial lymph tissue do 
not necessarily indicate genetic variation. However, in-
teractions among line, treatment, and class found for 
several genes are evidence that genetic variation in the 
mechanisms involved in immune responses to PRRSV 
exist.
One objective was to determine whether response to 
infection was a general characteristic of H- and L-class 
pigs or whether expression differences could be mea-
sured only in the presence of virus. From a genetic se-
lection standpoint, it would be desirable to select on a 
trait in uninfected pigs that is correlated with response 
in infected pigs. In this study, main effect of class was 
not significant for expression of any oligo for both tis-
sues; however, interaction of line × class existed for 4 
oligos, and interaction of treatment × class existed for 
6 oligos. Although exact pathways in immune responses 
to infection with PRRSV are not fully understood, fur-
ther study of the genes for which interaction existed 
could give rise to discoveries for genetic mechanisms 
involved in PRRSV immunity. Therefore, emphasis is 
placed on genes for which line × class and treatment 
× class interactions were significant in both lung and 
BLN (Table 5).
Expressions of DDX3 and Tβ4 were considerably 
greater in both lung and BLN of line I pigs with low 
PRRSV burden than in line I pigs with high PRRSV 
burden. Differences in expression of these oligos be-
tween L-class and H-class line HD pigs were relatively 
small. Different expression of 2 other oligos (ACHE and 
XIST) between L-class and H-class pigs also occurred 
in line I but not in line HD, but expression of each 
of these genes in line I was greater in pigs with high 
PRRSV burden than in those with low burden. Based 
on biological responses in pigs of this same experiment, 
Petry et al. (2005) concluded that line I pigs were more 
resistant to PRRSV than line HD pigs. Results reported 
herein suggest that DDX3, Tβ4, ACHE, and XIST may 
play a role, either directly or through genes in immune 
pathways, to genetic resistance to PRRSV.
The DEAD box proteins, RNA helicases, which 
contain the conserved amino acid motif Asp-Glu-Ala-
Asp, are essential in RNA metabolism, which includes 
RNA transport, transcription, spliceosome function, ri-
bosome assembly, initiation of translation, and RNA 
Table 4. Fold differences, relative to common control, in expression of genes in lung and bronchial lymph node 





High viremia Low viremia High viremia Low viremia
In Un SEM In Un SEM In Un SEM In Un SEM
NF-κBIα2 SS00000892 0.94 0.53 0.07 0.80 0.69 0.07 0.66 0.52 0.05 0.59 0.68 0.05
TXNIP3 SS00008321 0.74 0.52 0.08 0.56 0.73 0.08 1.51 0.90 0.19 1.22 1.58 0.19
MFSD14 SS00009186 1.28 0.80 0.06 1.14 0.94 0.06 1.21 0.87 0.08 0.82 0.85 0.08
CEBPδ5 SS00010698 1.21 0.75 0.07 0.92 0.93 0.07 1.10 0.84 0.09 0.92 1.03 0.10
Unknown SS00012040 1.47 0.76 0.07 0.87 0.60 0.07 1.29 0.90 0.11 0.78 0.95 0.10
Unknown SS00012343 1.15 0.86 0.06 0.95 0.91 0.06 0.93 0.63 0.06 0.90 0.92 0.06
1Oligonucleotide sequence, TIGR Tentative Consensus accession, and reference sequence identification numbers (ID) can be found in the supple-
mentary table of the online version of Zhao et al., 2005 (http://jas.fass.org/content/vol86/issue12).
2NF-κBIα = nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α.
3TXNIP = thioredoxin-interacting protein.
4MFSD1 = major facilitator superfamily domain containing 1.
5CEBPδ = CCAAT/enhancer-binding δ protein.
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degradation (Krishnan and Zeichner, 2004). These au-
thors also suggest that DDX3 may be important in hu-
man immunodeficiency virus (HIV) latency. The oligo 
DDX3 is found on the X chromosome of H. sapiens, 
Bos taurus, Gallus gallus, Mus musculus, Canis lupus 
familiaris, and Rattus norvegicus but is currently not 
mapped to a swine chromosome (http://www.ncbi.nlm.
nih.gov/sites/entrez?db = gene). Because of the loca-
tion conservation across several species, it is plausible 
that DDX3 is also on the swine X chromosome.
It has been found that DDX3 is a crucial compo-
nent in the pathogenesis of HIV and hepatitis C, and 
like PRRSV, HIV and hepatitis are also single-stranded 
positive RNA viruses. The precise biological function 
of DDX3 is not fully understood. However, DDX3 is 
known to harbor a cell growth-suppressive property, 
thus acting as a tumor suppressor (Chao et al., 2006), 
is required in viral replication of HIV and hepatitis C, 
and is involved in gene splicing (Kim et al., 2001; Krish-
nan and Zeichner, 2004; Ariumi et al, 2007).
The gene that encodes Tβ4, TMSB4X, is also found 
on the X chromosomes of H. sapiens, B. taurus, G. gal-
lus, and M. musculus (http://www.ncbi.nlm.nih.gov/
sites/entrez?db =gene), and like DDX3, Tβ4 is also not 
mapped to a swine chromosome. Thus, it is probable 
that TMSB4X is also on the swine X chromosome. In 
humans, TMSB4X escapes X inactivation (entrez gene: 
TMSB4X Tβ4, X-linked) caused by XIST.
Thymosin β-4 has many functions, including cell pro-
liferation, migration, and differentiation, and has also 
been shown to be involved in resistance to apoptosis 
(Muller and Hannappel, 2003; Hsiao et al., 2006). Cyto-
toxic T lymphocytes, natural killers, and lymphokine-
activated killers utilize the Fas ligand to trigger apop-
tosis (Berke 1995; Liu et al., 1995; Eischen et al., 1996). 
Hsiao et al. (2006) showed that overexpression of Tβ4 
increased the cellular apoptosis resistance of Fas ligand-
bearing T cells. Upon induction of apoptosis, a reduc-
tion in mRNA of Tβ4 has been shown, further suggest-
ing a role for Tβ4 in apoptosis (Muller and Hannappel, 
2003). Findings here along with those cited above sug-
gest that increased concentrations of Tβ4 in line I pigs 
with low PRRSV burden increased resistance to apop-
tosis, a primary effect of PRRSV infection.
Acetylcholinesterase is involved in protective immu-
nity. Possible roles of ACHE in immune response to 
PRRSV are difficult to postulate, but it too may be 
involved in apoptosis. Inhibition of ACHE has been 
shown to increase cell counts and enhance cellular pro-
liferation (Jiang et al., 2007). Phosphorylation of c-Jun 
N-terminal kinases (JNK) was enhanced during apop-
tosis and was coupled with increases in ACHE expres-
sion in apoptotic cells. The upregulation of ACHE was 
abolished after administrating a JNK inhibitor and si-
lencing JNK with small interfering RNA (Deng et al., 
2006).
Homo sapiens X (inactive)-specific transcript has 
been mapped to the swine X chromosome and is re-
sponsible for X inactivation in females (Ng et al., 2007). 
It is unlikely that XIST itself has an effect on immune 
response to PRRSV. However, XIST may indirectly 
affect immune response to PRRSV through inactiva-
tion of the second X chromosome in females, affect-
ing the expression of genes such as DDX3 or Tβ4. In 
males, however, a homolog of DDX3 is present on the 
Y chromosome (Kim et al., 2001). If DDX3 is an impor-
tant gene in immune response to PRRSV, sex-linked 
responses could occur. This experiment was too small 
and not designed so as to test that hypothesis.
We found that expression of 6 genes was greater in 
pigs infected with PRRSV and that they had a greater 
PRRSV burden than their uninfected littermates. How-
ever, there was little difference in expression of these 
genes between infected pigs with low PRRSV burden 
and their uninfected littermates. Thus, it appears that 
these are genes that are activated to a greater degree in 
Table 5. Genes and oligonucleotide identification number (ID) for significant differential expression (P < 0.01) in 




DEAD box RNA helicase 3 (DDX3) SS00006751 Controls RNA viral latency, RNA virus replication
Thymosin β-4 (Tβ4) SS00008272 Apoptosis inhibitor
Acetylcholinesterase (ACHE) SS00011278 Apoptosis regulator
Homo sapiens X (inactive)-specific transcript (XIST) SS00012135 X-chromosome silencer
Nuclear factor of κ light polypeptide gene enhancer  
 in B cells inhibitor α (NF-κBIα)
SS00000892 Innate anti-RNA virus response, RNA virus enhancer, apoptosis
Thioredoxin-interacting protein (TXNIP) SS00008321 Apoptosis enhancer, inhibits natural killer cell development,  
 increases cell growth arrest (G0 phase)
Major facilitator superfamily domain containing 1 
(MFSD1) 
SS00009186 Unknown
CCAAT/enhancer-binding δ protein (CEBPδ) SS00010698 Increases cell growth arrest (G0 phase)
Unknown SS00012040 Unknown
Unknown SS00012343 Unknown
1Oligonucleotide sequence, TIGR Tentative Consensus accession, and reference sequence ID can be found in the supplementary table of the 
online version of Zhao et al., 2005 (http://jas.fass.org/content/vol86/issue12).
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pigs that respond most to PRRSV, but there was no in-
nate difference detected between uninfected littermates 
of high and low responders.
The NF-κBIα gene inhibits the NF-κB pathway. Lee 
and Kleiboeker (2005) showed that upon PRRSV in-
fection in MARC-145 cells, the NF-κB pathway was 
activated as a result of NF-κBIα degredation, result-
ing in induction of reactive oxygen species (ROS). In 
that study, PRRSV infection induced oxidative stress 
in cells by generating ROS, and antioxidants inhibited 
NF-κB DNA binding activity in PRRSV-infected cells, 
suggesting ROS as a mechanism where NF-κB was ac-
tivated by PRRSV infection. It has been found that 
NF-κB plays a crucial role in apoptosis of virus-infected 
cells, and NF-κB activation may maximize viral repli-
cation through delaying cell death or increase the rate 
of apoptosis in infected cells as a mechanism to increase 
rate of spread of virus (Mi et al., 2001; Bowie et al., 
2004).
Infection in humans with viruses such as HIV (Israel 
and Gougerot-Pocidalo, 1997), influenza virus (Flory et 
al., 2000), and hepatitis C (Gong et al., 2001) activate 
the NF-κB pathway. It is plausible that expression of 
NF-κBIα in response to PRRSV is increased in some 
pigs (those with high PRRSV burden), affecting the 
NF-κB pathway, whereas this same level of activation 
did not occur in pigs with low PRRSV burden.
Thioredoxin-interacting protein, also known as vita-
min D3 upregulated protein 1, is important in cell sta-
bility, has numerous cellular functions, and can be in-
duced by several stress stimuli (Kim et al., 2007). They 
found that overexpression of TXNIP inhibited cellular 
proliferation through cell cycle arrest in the generation 
0 and generation 1 phases, whereas underexpression of 
TXNIP was strongly associated with tumorigenesis. A 
role for TXNIP in apoptosis has also been shown (Xi-
ang et al., 2005). It has been found that TXNIP in-
hibited the interaction between thioredoxin and apop-
tosis signal-regulating kinase 1 (ASK-1), resulting in 
increases in ASK-1 concentrations. It has been found 
that ASK-1 is important in cell cycle and proliferation, 
and activation of ASK-1 induces apoptosis through the 
JNK and p38 mitogen-activated protein kinase path-
way (Tobiume et al., 2001; Song and Lee, 2003).
Natural killer cells are important in innate immunity. 
One of their functions is the elimination of major his-
tocompatibility complex class-I-deficient virus-infected 
cells (Colucci et al., 2002; Moretta et al., 2002). Lee 
et al. (2005) showed that in TXNIP knockout mice, a 
significant reduction in natural killer cells occurred and 
that TXNIP is a critical factor in the development and 
function of these cells. Increased expression of TXNIP 
in infected H-class pigs compared with uninfected lit-
termates may have caused a reduction in natural killer, 
whereas this same event may not have occurred in pigs 
with low PRRSV burden.
Overexpression of TXNIP has also been shown to 
increase concentrations of ROS, which are often consid-
ered to be toxic stresses against cells. The regulation of 
the redox system is important in cell proliferation, gene 
expression, cell cycle, and apoptosis (Armstrong et al., 
2002; Liu and Chen, 2002; Vaculova et al., 2002; Rosato 
and Grant, 2003). Thioredoxin plays a protective role 
against oxidative stress and modulates DNA-binding 
activities of transcription of factors of the NF-κB path-
way (Kim et al., 2007).
Greater expression of CEPBδ occurred in both tis-
sues of infected than uninfected H-class pigs, whereas 
expression in infected L-class pigs and their uninfect-
ed littermates was very similar. Pathways by which 
CEPBδ are involved in immune response to PRRSV 
are not clear, but perhaps it is involved in cell growth 
and apoptosis. Cells with greater expression of CEPBδ 
exhibited a rapid decline of cyclin D1 and phosphory-
lated retinoblastoma protein concentrations, a rapid in-
crease in the cyclin-dependent kinase inhibitor 27, and 
accelerated generation 0 growth arrest and apoptosis 
(O’Rourke et al., 1999; Sivko et al., 2004). Upon resto-
ration of normal CEPBδ concentrations, O’Rourke et 
al. (1999) showed that generation 0 growth arrest and 
apoptosis returned to normal, suggesting that CEPBδ 
plays a key role in regulating generation 0 growth ar-
rest and apoptosis.
Expression of CEPBδ concentrations are generally 
low, but upon stimulation by interferon γ, IL1, IL6, li-
popolysaccharide, and tumor necrosis factor α, expres-
sion concentrations increase (Thangaraju et al., 2005). 
The CEPB genes are regulators of early inflammatory 
mediatators, including IL6, and tumor necrosis factor α 
(Chini et al., 1998; Poli, 1998; Fan et al., 2001). Using 
the same pigs as in this study, Petry et al. (2007) found 
that IL1B concentrations in lung were significantly 
greater in pigs infected with PRRSV than in their un-
infected littermates. Interleukin 1 in the lung is known 
to activate both CEPBδ and the NF-κB pathway (Sep-
panen et al., 2005). However, the NF-κB pathway has 
been shown to be repressed by NF-κBIα. Thus, in pigs 
with high PRRSV burden, the effect IL-1 has on the 
NF-κB pathway may also be repressed due to increases 
in NF-κBIα activity. Upon PRRSV infection, CEPBδ 
may be enhanced by IL-1, as well as other innate immu-
nity genes involved in regulation of CEPBδ, in particu-
lar STAT3, which has been shown to regulate CEPBδ 
(Thangaraju et al., 2005).
Increases in oxidative stress have also been coupled 
with increases in CEPBδ expression, suggesting a re-
lationship between CEPBδ and ROS (Alan and Papa-
constantinou, 1992; Choi et al., 1995; Sugahara et al., 
1999; Cassel and Nord, 2003). Henderson et al. (1995) 
demonstrated that upon HIV infection, CEPB pro-
teins play an essential role in transcription of HIV in 
macrophage-monocytes, suggesting a possible role for 
CEPBδ in transcription of PRRSV. This could explain 
why only infected pigs with high PRRSV burden had 
elevated concentrations of CEPBδ.
Major facilitator superfamily domain containing 
1, unknown oligo SS00012040, and unknown oligo 
SS00012343 were oligos for which differential expres-
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sion existed within treatment × class subclasses. The 
function of these 3 oligos is unknown, and thus poten-
tial pathways for their involvement in immune response 
to PRRSV cannot be postulated.
Fold differences in expression of oligos for which 
treatment × class was significant were relatively small. 
No expression differences between pigs with high and 
low PRRSV burden, regardless of infection status, were 
greater than 2-fold, a difference often considered im-
portant in gene expression studies. However, because 
a microarray analysis was done for each pig, adequate 
replication occurred to detect interactions with smaller 
fold differences in expression. In addition, some mRNA 
have relatively short half-lives, in particular CEPBδ, 
which has a half-life of ~35 min (Dearth and DeW-
ille, 2003). Relatively small changes in transcription or 
half-life of short-lived mRNA can result in significant 
(~1,000-fold) differences in mRNA content over a short 
period of time (Ross, 1996; Guhaniyogi and Brewer, 
2001). Therefore, the importance of oligos with smaller 
fold differences in expression should not be overlooked.
Results of this experiment provide insights into genes 
and possible mechanisms by which pigs are able to 
tolerate PRRSV infection and not show symptoms of 
porcine reproductive and respiratory syndrome. Many 
oligos found to be differentially expressed are known to 
interact with one another, indicating potential path-
ways involved in response to PRRSV infection. 
Many genes were found to be involved in the immune 
response to PRRSV. Genes including Tβ4, DDX3X, 
ACHE, and XIST, CEPBδ, NFκBIα, TXNIP, MFSD1, 
and unknown sequences SS00012040 and SS00012343 
need additional evaluation to determine their role in 
response to PRRSV infection. They are candidates for 
genes that could be included in selection for greater im-
munity to PRRSV, either through selection for allelic 
variants that allow resistance-tolerance to PRRSV, or 
selection on the gene products themselves. Although 
these genes may not be the only genes associated in the 
immune response to PRRSV, they do provide insight 
into the genetic mechanisms associated with the host 
immune response to PRRSV.
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